The Investor Relations website contains information about Pain Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
http://investor.paintrials.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
2.1 seconds
16x16
32x32
64x64
128x128
160x160
192x192
256x256
PAGES IN
THIS WEBSITE
16
SSL
EXTERNAL LINKS
35
SITE IP
23.55.218.214
LOAD TIME
2.068 sec
SCORE
6.2
CORPORATE OVERVIEW | Pain Therapeutics, Inc. | investor.paintrials.com Reviews
https://investor.paintrials.com
The Investor Relations website contains information about Pain Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
investor.paintrials.com
Pain Therapeutics - Shareholder Briefcase Registration
http://investor.paintrials.com/briefcase.cfm
X2022; Top Stories. Collect, zip and download files from our Investor Relations website. Click on the briefcase icon. Located near most downloadable files throughout our IR website and use this page to manage your briefcase. Please fill in the form below to access this feature. Type in number *. This helps Pain Therapeutics prevent automated submissions.
Pain Therapeutics - Board of Directors
http://investor.paintrials.com/directors.cfm
X2022; Top Stories. X2022; Executive Officers. X2022; Board of Directors. X2022; Committee Membership. Chairman of the Board, President and CEO. Nadav Friedmann PhD, MD. Chief Medical and Operating Officer. Member of the Audit Committee. Member of the Compensation Committee. Member of the Audit Committee. Chair of the Audit Committee. Member of the Compensation Committee. Patrick Scannon MD, PhD.
Pain Therapeutics - Corporate Overview
http://investor.paintrials.com/index.cfm
X2022; Top Stories. Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. Pain Therapeutics Stock Information. 4:00 PM ET on Aug 26, 2016. Quote delayed at least 20 minutes. Jul 19, 2016. Pain Therapeutics Reports Q2 2016 Financial Results. Jul 1, 2016. Pain Therapeutics Announces Advisory Committee Meeting for REMOXY Is Not Needed. View all releases ».
Pain Therapeutics - Events & Presentations
http://investor.paintrials.com/events.cfm
X2022; Top Stories. May 11, 2016. American Pain Society Poster. REMOXY: Human Abuse Potential Study of an Extended-Release Oxycodone Formulation. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Apr 13, 2016. Conference Call: FDA Accepts REMOXY NDA for Review. 1-877-407-4018 (U.S.). May 12, 2015. Pain Therapeutics Drug Portfolio Update. Add file to Briefcase.
Pain Therapeutics - Pain Therapeutics Announces Positive Top-Line Results From Human Abuse Potential Study With REMOXY
http://investor.paintrials.com/releasedetail.cfm?ReleaseID=912547
Laquo; Previous Release. Next Release ». Pain Therapeutics Announces Positive Top-Line Results From Human Abuse Potential Study With REMOXY. REMOXY Meets Both Primary Endpoints with Statistical Significance ( p. 60 00001) that both intact and chewed REMOXY were less "liked" than immediate-release oxycodone on the two primary endpoints, Drug Liking and Drug High. The Abuse Potential study was conducted in non-dependent, recreational opioid users, as recommended by FDA guidelines. On the co-primary endpoin...
TOTAL PAGES IN THIS WEBSITE
16
Investor Relations | Oxford Industries Inc.
Skip to main navigation. SEC and Financial Information. SEC and Financial Information. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Oxford Industries, Inc.'s financial performance into perspective. Oxford Reports Fourth Quarter and Full Fiscal Year 2017 Results. Oxford to Release Fourth Quarter and Fiscal 2017 Results on March 28, 2018. Mar 28,2018 4:30 PM.
Investors & Media | Oxigene
Efficiently Creating Value with Innovative Science. Day High: 1.35. Day Low: 1.27. Aug 7, 2015. Delayed 20 min., by eSignal. OXiGENE is highly committed to delivering value to its shareholders. Were working to translate innovative science into important, next-generation therapeutic products that deliver significant medical benefits to patients suffering from cancer. Our pipeline currently includes fosbretabulin and other preclinical and clinical stage therapeutic candidates. Aug 4, 2015. Jul 28, 2015.
investor.pacificbiosciences.com
INVESTOR RELATIONS | Pacific Biosciences of California
Skip to main navigation. ANNUAL REPORT and PROXY MATERIALS. Is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. Pacific Biosciences of California, Inc. Fourth Quarter 2017 Earnings Conference Call. Feb 1, 2018 1:30 PM PST. 36th Annual JP Morgan Healthcare Conference. Jan 8 11, 2018. Westin St. Francis. Piper Jaffray 29th Annual Healthcare Confernce. Nov 28 29, 2017.
Pacific Web Works, Inc.
If you are not taken to our investor section after 10 seconds click here.
Investors & Media - Company Overview - Pacira Pharmaceuticals, Inc.
10450 Science Center Drive. San Diego, CA 92121. Parsippany, NJ 07054. Q2 2015 Pacira Pharmaceuticals, Inc. Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Pacira Pharmaceuticals, Inc. Earnings Conference Call. Thursday, July 30, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. Pacira Pharmaceuticals, Inc. at 2015 Wedbush PacGrow Healthcare Conference. 160;at 8:00 am ET. Pacira Pharmaceuticals, Inc. at 2015 Wedbush PacGrow Healthcare Conference. PARSIPPANY,...
CORPORATE OVERVIEW | Pain Therapeutics, Inc.
Skip to main navigation. Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. Pain Therapeutics Stock Information. 12:38 AM EDT on Mar 30, 2018. Mar 19, 2018. Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER. Mar 01, 2018. FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of August 7, 2018.
Инвестиции в памм счета
Введите свое имя и рабочий e-mail адрес в форму ниже , после чего подтвердите подписку. В течении нескольких минут вы получите ссылку на скачивание курса.
Pandora - Investor Relations - Corporate Overview
Annual Report and Proxy. Pandora Media, Inc. at Needham Interconnect Conference. 160;at 9:20 am ET. Pandora Media, Inc. at Needham Interconnect Conference. Tuesday, August 4, 2015 . 9:20 am ET . Click here for webcast. Click here to add this event to your calendar. Pandora Media, Inc. at Pacific Crest Global Technology Leadership Forum. 160;at 11:30 am MT. Pandora Media, Inc. at Pacific Crest Global Technology Leadership Forum. Monday, August 10, 2015 . 11:30 am MT . Click here for webcast. Events to b...
PANDORA - Investor Relations
Vice President, Head of Investor Relations. LOUISE GYLLING JØRGENSEN. Transactions in connection with share buyback programme. Transactions in connection with share buyback programme. Silent period Q1 2018. Interim Report for the first quarter 2018. Conference: HSBC Luxury Goods Conference - Paris. Conference: Deutsche Bank Global Consumer Conference - Paris.
Stressklubben - Login
